My dad Htn on amlo 5 mg complaining of DIP from 2 months. Used aceclo for 1 week, jointace c2 . But pain is not subsiding.
amlodipine arthralgia joint pain DIP side effect hypertension
| Test | Reason |
|---|---|
| X-ray bilateral hands (PA view) | OA changes, erosions, pencil-in-cup deformity |
| Serum Uric Acid | Rule out gout |
| ESR, CRP | Inflammatory vs. non-inflammatory arthritis |
| RF, Anti-CCP | Rule out early RA (though RA spares DIP) |
| Serum Calcium | Rule out hypercalcemia |
| Skin exam | Look for psoriatic plaques (scalp, elbows, umbilicus, perianal) |
| Nail exam closely | Nail pitting (use magnification), onycholysis |
Important: The online assessment is not a substitute for clinical examination. The nail changes specifically need to be examined in person with magnification for pitting (which photographs can miss). A face-to-face visit with a physician - ideally a rheumatologist - is strongly recommended given the 2-month duration without response to initial treatment.
Observe index fingers of both. Nodes in DIP is seen
Heberden nodes DIP joint osteoarthritis finger

This composite figure provides a diagnostic comparison for a digital mucus cyst using two imaging modalities. Image A is a lateral plain radiograph of the index finger showing focal soft-tissue swelling (indicated by a yellow arrow) on the dorsal aspect of the distal interphalangeal (DIP) joint, located just proximal to the nail fold. There is no evidence of underlying bone erosion on the radiograph. Image B is a sagittal fat-suppressed proton density (PD) weighted MRI of the same finger. It reveals a small, well-circumscribed, uniformly hyperintense lesion consistent with a ganglion-type digital mucus cyst. The MRI confirms the absence of subungual extension or osseous erosion and demonstrates the cyst's location within the superficial soft tissues dorsal to the DIP joint. This visual material is used in medical education to differentiate between digital mucoid cysts, which are often associated with osteoarthritis and Heberden’s nodes, and other finger masses such as glomus tumors or giant cell tumors of the tendon sheath.

Clinical photograph of the dorsal aspect of a right hand demonstrating chronic tophaceous gout. The image prominently features two large, nodular, firm swellings (tophi) located at the distal interphalangeal (DIP) and proximal interphalangeal (PIP) joint regions of the second (index) and third (middle) digits, highlighted by black arrows. The larger mass on the index finger appears bulbous and irregular, with the overlying skin appearing thin, taut, and slightly erythematous or translucent, characteristic of underlying monosodium urate crystal deposition. Proximal to the metacarpophalangeal joints, a white medical dressing is visible on the wrist area, suggesting recent clinical intervention or intravenous access. The photograph illustrates advanced manifestations of gouty arthritis, emphasizing the typical presentation of tophi in the small joints of the hand. The clinical significance lies in identifying chronic hyperuricemia complications and distinguishing these masses from other rheumatological conditions like rheumatoid nodules or osteoarthritis-related Heberden's and Bouchard's nodes.
| Reason | Explanation |
|---|---|
| OA at DIP is structurally driven | Bony nodes = osteophytes - pain is from the joint lining, not just inflammation; short NSAIDs don't address the underlying degeneration |
| Aceclofenac only 1 week | Too brief for chronic OA |
| Jointace C2 needs months | Glucosamine/chondroitin/collagen takes 8-12 weeks minimum to show benefit in OA |
| Oral NSAIDs for small finger joints | Topical NSAIDs are now preferred first-line for hand OA due to equal efficacy with far less systemic risk - Rheumatology Textbook (Elsevier 2022) |
| Test | Purpose |
|---|---|
| X-ray hands PA view | Confirm OA (joint space narrowing, osteophytes, subchondral sclerosis); rule out erosive OA or gout |
| Serum Uric Acid | Gout can co-exist and worsen joint pain |
| ESR/CRP | If elevated, suggests inflammatory component or erosive OA |
Jointace used for 1 month only
glucosamine chondroitin hand osteoarthritis
| Timeframe | Action |
|---|---|
| Now | Stop oral aceclofenac, start topical diclofenac gel 3x daily + warm soaks |
| Now - 2 months | Continue Jointace C2 (complete 3 month total course) |
| Within 2 weeks | Get X-ray hands PA view |
| At 3 months | Review - if still painful, rheumatology referral for intra-articular steroid injection |
These are done 2 months back. Used vit d3 for 8 weeks
python3 -c " import pdfplumber with pdfplumber.open('/tmp/workspace/attachments/a5e2dcdd-9d74-4edd-839e-1c9ce967e8d7/Gopal.pdf') as pdf: for i, page in enumerate(pdf.pages): print(f'--- PAGE {i+1} ---') print(page.extract_text()) print() "
| Parameter | Value | Status | Significance |
|---|---|---|---|
| Vitamin D (25-OH Total) | 21.56 ng/mL | 🔴 Insufficient (20-<30) | Was insufficient BEFORE starting Vit D3 |
| Uric Acid | 6.89 mg/dL | ✅ Normal (< 7.3) | Rules out gout contributing to DIP pain |
| hs-CRP | 0.58 mg/L | ✅ Low risk (<1.0) | No systemic inflammation - strongly favours OA over inflammatory arthritis |
| Calcium | 10.15 mg/dL | ✅ Normal | Rules out hypocalcemia |
| Parameter | Value | Interpretation |
|---|---|---|
| Triglycerides | 181 mg/dL (>150) | Borderline high - dietary modification needed |
| Trig/HDL ratio | 3.5 (>3.12) | Mildly elevated - insulin resistance pattern, not dangerous |
| eGFR | 82 mL/min/1.73m² | Mildly reduced - CKD Stage G2 |
| Albumin | 5.01 g/dL (>4.8) | Mildly high - likely dehydration artifact |
| Total Protein | 8.42 g/dL | Mildly high - same, dehydration |
| MCHC | 28.9 g/dL (low) | Hypochromic RBCs |
| RDW-SD | 49.5 fL (high) | Anisocytosis - mixed picture |
| Mentzer Index | 18.9 (>13) | Points toward Iron Deficiency Anemia pattern |
| HbA1c | 5.6% | Pre-diabetic range (5.7 cut-off) - monitor annually |
| TSH | 1.884 | Normal |
| Uric Acid | 6.89 | High-normal - watch dietary purines |
⚠️ NSAIDs are relatively contraindicated with eGFR <90 + hypertension. Oral aceclofenac was the wrong choice. This makes topical diclofenac gel even more important as the safe alternative.
Shall i add ultracet?
| Concern | Detail |
|---|---|
| Dizziness / falls | Most common side effect of tramadol is dizziness, vertigo, sedation - in a 56-year-old man, this is a real fall risk, especially at night |
| Nausea/vomiting | Very common on starting; start with half a tablet (1/2 tab) for the first 3 days |
| Serotonin syndrome | Rare but possible - check if he is on any antidepressant (SSRIs/SNRIs) - avoid combination |
| Seizure threshold | Tramadol lowers seizure threshold - relevant if he has any history of seizures |
| Constipation | Tramadol causes constipation; ensure adequate water and fibre intake |
| Dependence | Lower risk than full opioids, but avoid using daily for more than 2-3 weeks without review |
Topical diclofenac gel → if insufficient → add plain paracetamol TDS → if still insufficient → add Ultracet 1 tab nocte/BD for 2-4 weeks
Shall i do ESR , RA FACTOR, ANTI CCP?
| Test | Order It? | Reason |
|---|---|---|
| ESR | ✅ Yes - useful | Cheap, gives inflammatory baseline, complements hs-CRP |
| RA Factor | ⚠️ Low yield, but reasonable | Will almost certainly be negative - read why below |
| Anti-CCP | ⚠️ Low yield, but reasonable | Same reason - but if positive, changes everything |
"Rheumatoid arthritis usually spares the DIP joints and the small joints of the toes."
"Anti-CCP antibodies have high specificity 93-98% for RA, may be present years before clinical disease, and are associated with aggressive erosive disease."
Do ESR - cheap, quick, useful baseline. If ESR is elevated (>40 mm/hr), then add anti-CCP.
Skip RF - not worth the cost or confusion. Low specificity, high false-positive rate in elderly males.
Anti-CCP - only if ESR comes back elevated OR if you see any MCP/PIP/wrist involvement on examination that was missed.
ESR result
│
├── Normal (<20 mm/hr) → Confirms OA, no further serology needed
│
└── Elevated (>40 mm/hr) → Add Anti-CCP + refer rheumatology
(reconsider psoriatic arthritis or early RA)